Bruce Theresa Margaret Ms 4
4 · NuCana plc · Filed Apr 16, 2026
Research Summary
AI-generated summary of this filing
NuCana (NCNA) COO Theresa Bruce Receives Option Award
What Happened
- Theresa Bruce, Chief Operating Officer of NuCana plc, received a grant of options covering 132,600,130 ordinary shares on April 15, 2026. The transaction is reported as a derivative award (code A) with a reported acquisition amount of $0.00. The underlying options carry an exercise price of £0.0004 per share.
- This was an award/grant (not an open‑market purchase or sale). Fifty percent of the shares underlying the option vested on April 15, 2026; the remainder vests in four equal annual installments thereafter, subject to continued service.
Key Details
- Transaction date: 2026-04-15; filing date: 2026-04-16 (timely filing).
- Reported consideration: $0.00 (derivative award). Exercise price of underlying Ordinary Shares: £0.0004 per share (footnote F1).
- Vesting: 50% vested on Apr 15, 2026; remaining 50% vests in four equal annual installments (footnote F2).
- Shares owned after the transaction: not specified in the provided excerpt of the filing.
- Transaction type/code: A = Award/Grant of derivative securities (stock options).
Context
- This was an option grant, not an immediate purchase of stock; Bruce must exercise the options (and meet any tax/holding conditions) to acquire ordinary shares. The initial 50% vesting means some options are immediately exercisable subject to the exercise price and any company restrictions, while the remainder vests over the next four years contingent on continued service. The filing does not indicate any immediate sale of shares.
Insider Transaction Report
Form 4
NuCana plcNCNA
Bruce Theresa Margaret Ms
Chief Operating Officer
Transactions
- Award
Options
[F1][F2]2026-04-15+132,600,130→ 132,600,130 totalExp: 2036-04-15→ Ordinary Shares (132,600,130 underlying)
Footnotes (2)
- [F1]The ordinary shares, nominal value 0.0004 Pounds Sterling per share (the "Ordinary Shares"), of NuCana plc (the "Company") underlying this option have an exercise price of 0.0004 Pounds Sterling.
- [F2]The shares underlying this option vested as to 50% on April 15, 2026, with the remainder to vest in four equal annual installments thereafter, subject to the Reporting Person's continued service with the Company through the applicable vesting date.
Signature
/s/ Ian Webster, Attorney-in-Fact for Theresa Bruce|2026-04-16